FDA issues warning letter to API manufacturer in Japan

13:56 PM | April 5, 2013 | Deepti Ramesh

US FDA issued a warning letter late last month to the active pharmaceutical ingredient (API) manufacturing facility of Asada Milling Co. (Kanra, Japan), for deviating from cGMP. An FDA inspection of...